Aurora Cannabis Holds 2024 Annual Meeting, Elects Directors

Ticker: ACB · Form: 6-K · Filed: 2024-08-12T00:00:00.000Z

Sentiment: neutral

Topics: annual-meeting, corporate-governance, news-release

Related Tickers: ACB

TL;DR

Aurora Cannabis shareholders voted on directors and auditors at their 2024 annual meeting.

AI Summary

Aurora Cannabis Inc. announced the results of its 2024 Annual General and Special Meeting held on August 12, 2024. Key resolutions passed included the election of directors and the appointment of auditors. The company's CEO, Miguel Martin, signed off on the report.

Why It Matters

The meeting's outcomes are crucial for corporate governance, confirming the board of directors and auditor, which impacts investor confidence and operational oversight.

Risk Assessment

Risk Level: low — This filing is a routine update on the results of an annual general meeting and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What type of report is Aurora Cannabis Inc. filing?

Aurora Cannabis Inc. is filing a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

When was the 2024 Annual General and Special Meeting held?

The 2024 Annual General and Special Meeting was held on August 12, 2024.

Who signed the Form 6-K report on behalf of Aurora Cannabis Inc.?

Miguel Martin, Chief Executive Officer, signed the report on behalf of Aurora Cannabis Inc.

What is the principal executive office address for Aurora Cannabis Inc.?

The principal executive office address is 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada.

What exhibit is submitted with this Form 6-K filing?

Exhibit 99.1, a News Release dated August 12, 2024, is submitted with this Form 6-K filing.

From the Filing

0001279569-24-001007.txt : 20240812 0001279569-24-001007.hdr.sgml : 20240812 20240812135403 ACCESSION NUMBER: 0001279569-24-001007 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20240812 FILED AS OF DATE: 20240812 DATE AS OF CHANGE: 20240812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241196084 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated August 12, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: August 12, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED AUGUST 12, 2024 Exhibit 99.1 Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting NASDAQ | TSX: ACB EDMONTON, AB, Aug. 12, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" ) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the " Meeting ") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date. All of the matters put forward before shareholders for consideration and approval, as set out in the Company's Management Information Circular dated June 26, 2024, were approved by the requisite majority of votes cast at the Meeting. The details of the voting results for the election of directors are set out below: Name of Nominee Votes FOR % votes FOR Votes WITHHELD % votes WITHHELD Ron Funk 3,616,439 79.26 % 946,218 20.74 % Miguel Martin 4,256,348 93.29 % 306,310 6.71 % Chitwant Kohli 4,214,368 92.37 % 348,289 7.63 % Theresa Firestone 3,658,118 80.18 % 904,540 19.82 % Norma Beauchamp 4,082,278 89.47 % 480,380 10.53 % Michael Singer 3,864,639 84.70 % 698,020 15.30 % Rajesh Uttamchandani 3,906,540 85.62 % 656,118 14.38 % Shareholders also approved the following matters: the appointment of Ernst & Young LLP as auditors of the Company for the ensuing year; amendments to the Company's RSU Plan, PSU Plan, DSU Plan and Share Option Plan; the renewal of the Company's Shareholder Rights Plan; and a non-binding advisory resolution on the Company's approach to executive compensation. The Company has filed a report of voting results on all resolutions voted on at the Meeting under its profile on www.sedar.com. About Aurora Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alber

View on Read The Filing